XML 26 R37.htm IDEA: XBRL DOCUMENT v2.4.0.8
BUSINESS COMBINATIONS AND ACQUISITIONS (Details) (USD $)
In Millions, except Per Share data, unless otherwise specified
Sep. 30, 2014
Optimer Pharmaceuticals, Inc.
right
Oct. 24, 2013
Optimer Pharmaceuticals, Inc.
right
Sep. 30, 2014
Trius Therapeutics, Inc.
Sep. 11, 2013
Trius Therapeutics, Inc.
right
BUSINESS COMBINATIONS AND ACQUISITIONS        
Percentage of issued and outstanding shares purchased   100.00%   100.00%
Tender offer purchase price of outstanding common stock of acquiree (in dollars per share)   $ 10.75   $ 13.50
Number of contingent value rights receivable by stockholders of acquiree 1 1   1
Maximum additional cash payment per share (in dollars per share)   $ 5.00   $ 2.00
Undiscounted contingent consideration payout $ 253.9 $ 253.9 $ 108.4 $ 108.4